all report title image

DIABETIC RETINOPATHY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Diabetic Retinopathy Market, By Disease Type (Proliferative Diabetic Retinopathy and Non-proliferative Diabetic Retinopathy), By Treatment Type (Anti-Vascular Endothelial Growth Factor Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy, and Others), By Route of Administration (Intravitreal Injections, Intravitreal Implants, Oral, Topical Eye Drops, Laser Surgery, and Others), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers, Long-Term Care Centers, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In: 03 Apr, 2026
  • Code: CMI3313
  • Page number: 140
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Diabetic Retinopathy Market, By Disease Type
      • Global Diabetic Retinopathy Market, By Treatment Type
      • Global Diabetic Retinopathy Market, By Route of Administration
      • Global Diabetic Retinopathy Market, By End User
      • Global Diabetic Retinopathy Market, By Distribution Channel
      • Global Diabetic Retinopathy Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Driver
      • Restraint
      • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Diabetic Retinopathy Market, By Disease Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Proliferative Diabetic Retinopathy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Non-proliferative Diabetic Retinopathy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Diabetic Retinopathy Market, By Treatment Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Anti-Vascular Endothelial Growth Factor Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Intraocular Steroid Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Laser Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Vitrectomy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others (Intraocular Corticosteroids, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Diabetic Retinopathy Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Intravitreal Injections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Intravitreal Implants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Topical Eye Drops
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Laser Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Diabetic Retinopathy Market, By End User, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Ophthalmology Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Long-Term Care Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Diabetic Retinopathy Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Diabetic Retinopathy Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  10. Competitive Landscape

    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Regeneron Pharmaceuticals Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Roche Holding AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Allergan PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Zeiss International
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Topcon Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Heidelberg Engineering GmbH
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Optos PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Canon Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Nidek Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ellex Medical Lasers Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bausch + Lomb Incorporated
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Santen Pharmaceutical Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Diabetic Retinopathy Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.